antiretroviral therapy Press Release

Title Picture
08/06/2018 - 21:31
Balzer, International Team Lead Community-Based HIV Trial in East Africa
University of Massachusetts Amherst's picture
University of M...
07/25/2018 - 12:16
Fauci: HIV remission free of antiretroviral therapy is a feasible goal
National Institutes of Health's picture
NIH
07/25/2018 - 12:04
Multi-disease health fairs, universal test and treat help East African communities achieve HIV benchmarks
National Institutes of Health's picture
NIH
07/25/2018 - 09:44
New Data Show Dramatic Progress in Namibia Toward HIV Epidemic Control and Substantial Gaps in Cote d'Ivoire and Cameroon
Centers for Disease Control and Prevention's picture
CDC
07/25/2018 - 02:53
Hologic's Global Access Initiative Increases Availability of Diagnostic Testing in Resource-Limited Countries
Hologic's picture
Hologic
07/24/2018 - 17:33
Abbott Introduces Breakthrough Point-of-Care Test, the m-PIMA HIV-1/2 Viral Load (VL), at AIDS 2018 Amsterdam
Abbott's picture
Abbott
07/24/2018 - 15:22
Janssen announces JULUCA (dolutegravir/rilpivirine) maintains viral suppression with two drugs in a once-daily, single-pill
Johnson and Johnson's picture
Johnson and Johnson
07/12/2018 - 15:19
Imaging technique illuminates immune status of monkeys with HIV-like virus
National Institutes of Health's picture
NIH
06/29/2018 - 18:36
Leading World-Class Investigations Into Infectious Diseases
Northwestern University's picture
Northwestern Un...
06/27/2018 - 15:48
HIV Test and Treat pilot project in Yambio comes to a close
Médecins Sans Frontières's picture
MSF
06/13/2018 - 22:11
ViiV Healthcare reports landmark phase III studies for dolutegravir and lamivudine, demonstrating the ability to control HIV with a two-drug regimen in treatment naive patients
GlaxoSmithKline's picture
GlaxoSmithKline
05/21/2018 - 08:51
Janssen Announces European Commission Approval of JULUCA (dolutegravir/rilpivirine), the First Two-Drug Regimen, Once-Daily, Single-Pill for the Treatment of HIV-1
Johnson and Johnson's picture
Johnson and Johnson
05/21/2018 - 04:41
ViiV Healthcare receives EU marketing authorisation for Juluca (dolutegravir/rilpivirine), the first 2-drug regimen, once-daily, single-pill for the treatment of HIV
GlaxoSmithKline's picture
GlaxoSmithKline
05/07/2018 - 06:27
NIH clinical trial to track outcomes of kidney transplantation from HIV-positive donors to HIV-positive recipients
National Institutes of Health's picture
NIH
04/18/2018 - 12:40
Top HIV Cure Research Team Refutes Major Recent Results on How to Identify HIV Persistence
Wistar Institute's picture
Wistar Institute
03/23/2018 - 04:10
ViiV Healthcare gains CHMP positive opinion for Juluca (dolutegravir/rilpivirine) in Europe
GlaxoSmithKline's picture
GlaxoSmithKline
03/19/2018 - 06:00
The Campbell Foundation Awards $100,000 Grant to The Wistar Institute
Wistar Institute's picture
Wistar Institute
03/06/2018 - 12:49
Center for Drug Use and HIV/HCV Research at NYU Meyers Receives $7.5 Million in NIH Funding, Marking Centers 20th Anniversary
New York University's picture
NewYorkUniversity
03/05/2018 - 10:57
One-month tuberculosis prophylaxis as effective as nine-month regimen for people living with HIV
National Institutes of Health's picture
NIH
03/05/2018 - 05:41
Broadly neutralizing antibody treatment may target viral reservoir in monkeys
National Institutes of Health's picture
NIH
03/01/2018 - 09:22
Merck to Present New Data from Studies of Investigational HIV Therapies Doravirine and MK-8591 at CROI 2018
Merck's picture
Merck
02/19/2018 - 13:01
Center for HIV Cure Research
Gladstone Institutes's picture
Gladstone Institutes
02/15/2018 - 10:54
UCLA scientists receive $7.7 million grant to study HIV recurrence
University of California Los Angeles's picture
UCLA
02/08/2018 - 07:09
ViiV Healthcare launches eighth phase III study in two-drug regimen programme for HIV-1 treatment
GlaxoSmithKline's picture
GlaxoSmithKline
01/25/2018 - 16:12
Gene therapy using CAR T cells could provide long-term protection against HIV
University of California Los Angeles's picture
UCLA
01/24/2018 - 01:43
15 years later, PEPFAR continues to save lives
National Institutes of Health's picture
NIH
01/24/2018 - 01:05
Study links gut-homing protein levels with HIV infection risk, disease progression
National Institutes of Health's picture
NIH
01/24/2018 - 01:04
NIH begins large HIV treatment study in pregnant women
National Institutes of Health's picture
NIH
01/22/2018 - 03:32
Gladstone Launches Three New Research Centers
Gladstone Institutes's picture
Gladstone Institutes
01/04/2018 - 12:05
Roche launches the cobas Plasma Separation Card to increase access to HIV testing for patients living in remote areas
Rocheusa's picture
Rocheusa
12/23/2017 - 03:34
UNAIDS welcomes appointment of Henrietta Holsman Fore as Executive Director of UNICEF
Joint United Nations Programme on HIV/AIDS's picture
UNAIDS
12/15/2017 - 09:17
Teva Announces Exclusive Launch of Generic Viread in the United States
Teva Pharmaceutical's picture
Teva Pharmaceutical
12/12/2017 - 21:19
Social stigma obstacle to successful treatment of children with HIV in Ethiopia
Lund University's picture
LundUniv
12/12/2017 - 13:34
Michel C. Nussenzweig wins 2017 Sanofi-Institut Pasteur Award
Rockefeller University's picture
RockefellerUniv...
12/11/2017 - 14:23
Marijuana may help HIV patients keep mental stamina longer
Michigan State University's picture
Michigan State ...
12/06/2017 - 15:58
Huge progress in treating AIDS
Harvard Public Affairs & Communications's picture
Harvard
12/05/2017 - 19:04
West and Central Africa left behind in global HIV response
Joint United Nations Programme on HIV/AIDS's picture
UNAIDS
12/01/2017 - 15:46
Six Caribbean territories and states eliminate mother-to-child transmission of HIV and syphilis
Joint United Nations Programme on HIV/AIDS's picture
UNAIDS
12/01/2017 - 13:06
NIH Statement on World AIDS Day 2017
National Institutes of Health's picture
NIH
12/01/2017 - 11:24
Ukraine: People co-infected with HIV to receive hepatitis C treatment in Mykolaiv region
Médecins Sans Frontières's picture
MSF
12/01/2017 - 10:09
Rising levels of HIV drug resistance
University College London's picture
UniversityColle...
11/29/2017 - 20:00
Combination HIV prevention reduces new infections by 42 percent in Ugandan district
National Institutes of Health's picture
NIH
11/21/2017 - 02:23
Juluca (dolutegravir and rilpivirine) approved in US as first 2-drug regimen, once-daily, single pill - a complete regimen for the maintenance treatment of virologically suppressed HIV-1 infection
GlaxoSmithKline's picture
GlaxoSmithKline
11/20/2017 - 01:31
UNAIDS announces nearly 21 million people living with HIV now on treatment
Joint United Nations Programme on HIV/AIDS's picture
UNAIDS
11/06/2017 - 11:09
The Wistar Institute Awarded More Than $16.5M in Grants to Fund Cancer & Infectious Disease Research and Training
Wistar Institute's picture
Wistar Institute
10/30/2017 - 18:58
WHO report signals urgent need for greater political commitment to end tuberculosis
World Health Organization's picture
WHO
10/26/2017 - 03:15
US: Trump Policy Harming Kenya, Uganda Health Services
Human Rights Watch's picture
Human Rights Watch
10/20/2017 - 12:42
HIV Patients Can Control the Virus, but Theyre Still Hoping for a Cure
Gladstone Institutes's picture
Gladstone Institutes
10/18/2017 - 04:13
National roll-out of PrEP HIV prevention drug would be cost-effective
University College London's picture
UniversityColle...
10/10/2017 - 07:19
Durable end to the HIV/AIDS pandemic likely will require an HIV vaccine
National Institutes of Health's picture
NIH
10/05/2017 - 12:40
Researchers create molecule that could kick and kill HIV
University of California Los Angeles's picture
UCLA
10/04/2017 - 20:42
SAMHSA awards $166 million for HIV prevention and treatment
Substance Abuse and Mental Health Services Adminis...'s picture
SAMHSA
10/03/2017 - 11:04
UNAIDS warns that HIV-related stigma and discrimination is preventing people from accessing HIV services
Joint United Nations Programme on HIV/AIDS's picture
UNAIDS
09/28/2017 - 11:03
Indonesian prisoners with HIV getting aid from UIC researchers
University of Illinois's picture
UICUniv
08/30/2017 - 14:06
Tick Saliva May Hold Potential Treatment for Reducing HIV-linked Heart Disease Risk
University of Pittsburgh Medical Center's picture
UPMC
08/30/2017 - 13:14
NIAID scientists illuminate mechanism of increased cardiovascular risks with HIV
National Institutes of Health's picture
NIH
08/07/2017 - 21:51
Mylan Launches Avonza in India
Mylan's picture
Mylan
07/25/2017 - 09:48
ViiV Healthcare announces superior efficacy of dolutegravir versus lopinavir/ritonavir in second-line HIV treatment in resource-limited settings
GlaxoSmithKline's picture
GlaxoSmithKline
07/25/2017 - 09:05
Switching to a dolutegravir regimen from a boosted protease inhibitor regimen maintained viral suppression and improved lipid fractions in patients with HIV and high cardiovascular risk
GlaxoSmithKline's picture
GlaxoSmithKline
07/25/2017 - 04:09
HIV: MSF concerned by high numbers of AIDS deaths in sub-Saharan Africa
Médecins Sans Frontières's picture
MSF